FDA NDC Directory · JSON-LD · Markdown

RETROVIR

NDC 49702-211 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namezidovudine
Labeler / ManufacturerViiV Healthcare Company
Marketing categoryNew Drug Application (innovator) · App NDA019655
Dosage form / routeCAPSULE · ORAL
Active ingredientsZIDOVUDINE (100 mg/1)
Marketing started20101028
Package count1

External sources

Source: openFDA. Public-domain (CC0).